pharma jobs

Latest Headlines

Latest Headlines

Europe may be austere, but it's also hiring in pharma

According to a report from corporate recruiters ZRG Partners, the biggest increase in pharma hiring for the first quarter came in the Austerity-R-Us region, Europe.

GSK to build new U.K. site, create up to 1,000 jobs

GSK said it will build a new facility in Ulverston, Cumbria, to boost production of ingredients for its meds and vaccines.

Novartis staffers stop work at Nyon plant in jobs protest

Swiss workers haven't taken Novartis' ($NVS) job-cutting plans lying down. First, union members and political activists joined protests in Basel--including one at Chairman Daniel Vasella's (photo)

No new cost-cutting, Roche chairman pledges

For Roche, 4,800 job cuts is enough. That's what Chairman Franz Humer told a Swiss newspaper over the weekend. Humer said the Basel-based company's current cost-squeezing program will suffice,

Integrating Cephalon, Teva eyes up to 1,500 job cuts

Hard on the heels of its merger with Cephalon, Teva Pharmaceutical Industries ($TEVA) is sharpening its jobs axe. Israeli news sources report anywhere from 1,000 to 1,500 cuts, with most of the

Sanofi plans hundreds more U.S. job cuts in sales, R&D

In yet another pharma-layoffs development, hundreds of U.S. Sanofi employees will lose their jobs over the next several months as the company absorbs Genzyme ($GENZ) and prepares for loss of

Basel protestors march against Novartis cuts

Novartis ($NVS) Chairman Daniel Vasella (photo) got a pink slip on Saturday. Don't be shocked--it was a fake, presented in protest of 1,000-plus job cuts planned for the drugmaker's Swiss operations,

New job opportunities emerging in Big Pharma

Since 2001, 300,000 pharma employees have lost their jobs, primarily in R&D and sales. That's according to Clifford Mintz, the founder of BioInsights, which develops and offers bioscience

Must-attend AAPS sessions for the biopharma job hunter

The pharmaceutical industry has been hit with round after round of massive layoffs in the last several years. Tens of thousands job cuts from big companies like Merck ($MRK), AstraZeneca ($AZN) and

AstraZeneca targets U.S. ops for 400 job cuts

Another Big Pharma company is taking the scalpel to its U.S. operations. AstraZeneca ($AZN) says it will cut 400 jobs from its commercial business in the U.S., with most of the cuts centered on its